反応式
[NH2:1][C:2]12[CH2:9][CH2:8][C:5]([C:10]([O:12][CH2:13][CH3:14])=[O:11])([CH2:6][CH2:7]1)[CH2:4][CH2:3]2.C(N(C(C)C)CC)(C)C.Br[CH2:25][C:26]([N:28]1[CH2:32][CH2:31][CH2:30][C@H:29]1[C:33]#[N:34])=[O:27]>CN(C)C=O>[CH2:13]([O:12][C:10]([C:5]12[CH2:4][CH2:3][C:2]([NH:1][CH2:25][C:26]([N:28]3[CH2:32][CH2:31][CH2:30][C@H:29]3[C:33]#[N:34])=[O:27])([CH2:9][CH2:8]1)[CH2:7][CH2:6]2)=[O:11])[CH3:14]参加物
5
反応物 3
生成物 1
試薬・触媒・溶媒 1
実験手順
Ethyl 4-aminobicyclo[2.2.2]octane-1-carboxylate (115 mg) was dissolved in N,N-dimethylformamide (1.5 mL) and diisopropylethylamine (100 μL) was added to the solution. (2S)-1-(2-Bromoacetyl)pyrrolidine-2-carbonitrile (120 mg) in N,N-dimethylformamide (1 mL) was then added dropwise at room temperature. The mixture was stirred for 2 hours at room temperature and was concentrated under reduced pressure. The residue was purified by silica gel column chromatography (eluant:chloroform:methanol=10:1) to give (2S)-1-[[N-(4-ethoxycarbonylbicyclo[2.2.2]oct-1-yl)amino]acetyl]pyrrolidine-2-carbonitrile (95.1 mg).
後処理
- concentrationwas concentrated under reduced pressure
- customThe residue was purified by silica gel column chromatography (eluant:chloroform:methanol=10:1)
出典と根拠
- ORDレコード
- ord-df5d7235011248d1a2dd7864f1328019
- 出典データセット
- uspto-grants-2011_11
- 特許番号
- US08053465B2
関連ノート
読み込み中…